Further studies are needed to elucidate the mechanism by which muscle contraction decreases the REDD1 expression in contracted muscles and to explore the potential therapeutic implications of targeting REDD1 in muscle hypertrophy and metabolic disorders. This evidence concerns the gene DDIT4 and Other metabolic disease.